VVKT Lithuania Drug Approval: Sourcing Baltic Pharma from India

Lithuania as a Market for Indian Generic Medicines

Lithuania is a small but well-regulated EU market. Hospitals, pharmacy chains and wholesalers are under steady pressure to keep treatment costs down, so quality generics are in demand. Indian manufacturers supply a large share of the world's generics, but Lithuania is not a market where a product can simply be shipped and sold. It follows EU pharmaceutical law, and the national authority is the State Medicines Control Agency (Valstybinė vaistų kontrolės tarnyba, VVKT) under the Ministry of Health.

This guide is for importers, distributors and tender buyers who want to bring Indian-manufactured generics into Lithuania. It explains the roles, documents and steps involved. Requirements change, so always confirm current rules with VVKT before committing to a programme.

Understand the Regulatory Framework First

Because Lithuania is an EU member state, three layers apply to any imported medicine:

• Marketing authorisation (MA): A medicine must hold an MA before it is placed on the market. Routes include the national procedure through VVKT, the mutual recognition or decentralised procedures across several member states, or the centralised procedure through the European Medicines Agency for eligible products.
• Import authorisation: A company importing medicines from outside the EU/EEA needs a manufacturing/import authorisation for the relevant activities, issued by the competent authority of the member state.
• Wholesale distribution authorisation: Companies storing and distributing medicines need a wholesale licence and must follow EU Good Distribution Practice.

In practice, the Lithuanian buyer or an EU-based marketing authorisation holder (MAH) is the regulatory face of the product. An Indian exporter or merchant exporter cannot hold the MA directly without an EU-established legal entity. Our role is to supply the product, the technical file and the export documents that your regulatory team needs.

Key Requirements for Indian-Manufactured Products

EU GMP Compliance of the Manufacturing Site

Finished products made outside the EU must come from a site that complies with EU GMP standards. The site is usually inspected by an EU authority, or its compliance is otherwise accepted under the applicable rules. Importers should ask for evidence of the site's inspection status and check relevant entries in the EU's public GMP databases. If a supplier cannot show this, the product is unlikely to be viable for the Lithuanian market.

QP Certification and EU Batch Testing

Every batch imported from a third country must go through quality control testing in the EU/EEA and be certified by a Qualified Person (QP) at an authorised importer before release. Plan for this step in your supply chain. Choose an importer site that can carry out the testing and QP release, and agree the analytical method transfer with the manufacturer early.

The Registration Dossier

A generic MA application is normally submitted in the Common Technical Document (CTD) format. It includes quality data, bioequivalence evidence against the reference product where required, and stability studies suited to the climatic zone and EU guidelines. Tuli Enterprise can coordinate CTD dossier support and stability data from our manufacturing partners. Your regulatory consultant or MAH will then adapt and submit it according to the chosen procedure.

Documents Lithuanian Buyers Usually Request

• Certificate of Pharmaceutical Product (COPP) and Free Sale Certificate from the Indian regulator
• Certificate of Analysis (CoA) for each batch
• CTD dossier modules and stability data
• Evidence of the manufacturing site's GMP status from partner facilities
• Commercial invoice, packing list, airway bill or bill of lading
• Product specifications, shelf-life details and storage conditions
• Draft artwork for cartons, blisters and leaflets

For a deeper look at how these papers fit together, see our insights article on pharmaceutical import documentation.

Labelling and Language

Packaging and the package leaflet for medicines sold in Lithuania must follow EU labelling rules and be provided in Lithuanian. Details such as the MAH name, authorisation number, batch number, expiry date and the product's safety features must also be handled correctly. Agree the artwork with your regulatory team before printing, because changes after production are expensive. Our partners can accommodate market-specific packaging and serialisation requirements, subject to confirmed order volumes.

Practical Sourcing Steps

1. Define your portfolio. Review molecules with an established generic market in Lithuania. Browse our product catalogue or filter by therapeutic category to build a shortlist.
2. Check the regulatory position. Determine whether each product already has an MA in Lithuania or another EU state, or whether a new application is required.
3. Request technical documents. Ask for the CTD dossier, stability data, sample CoAs and site information.
4. Select your EU importer and QP site. Make sure the company holds the right authorisations and can handle batch testing.
5. Run a pilot order. Start with a limited quantity to validate quality, documents, packaging and logistics.
6. Scale up with a supply agreement. Set forecast, lead time, pricing and quality terms once the first shipment has cleared.

MOQ, Lead Time and Pricing

Minimum order quantities depend on the product, pack format and whether custom artwork is needed. Standard export packs usually have lower MOQs than market-specific packaging. Lead times vary according to production schedules, packaging approval and the QP release process, so ask for a written estimate with each quotation. Cold-chain items and heat-sensitive products need dedicated logistics planning. We do not quote fixed timelines here, because each programme depends on the molecule and its regulatory status.

Private Label and Contract Manufacturing

Some Lithuanian distributors prefer to own a brand or secure exclusive rights to a formulation. In that case, third-party manufacturing may be the better route. It lets you specify composition, packaging and branding while leaving production to experienced partner facilities. Learn more on our contract manufacturing page. Any private-label product still needs an MA and compliant EU release.

Common Pitfalls to Avoid

• Assuming an Indian export certificate replaces an EU marketing authorisation
• Selecting a manufacturing site without confirming its EU GMP status
• Overlooking the time needed for QP release and EU batch testing
• Approving artwork without checking Lithuanian-language requirements
• Comparing suppliers on price alone without examining documents and stability data

If you also supply other European markets, our country guides explain how requirements differ between them.

Start Your Enquiry with Tuli Enterprise

Tuli Enterprise is a New Delhi-based merchant exporter supplying generic medicines to more than 95 countries, and we are members of PHARMEXCIL and FPME. We work with GMP-certified manufacturing partners and can provide COPP, CoA, CTD dossiers, Free Sale Certificates and stability data. To discuss your Lithuanian requirements, use our contact form, message us on WhatsApp at wa.me/919654308142, or email [email protected]. Tell us the products, quantities and your regulatory route, and we will respond with a structured quotation.